Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05244486 · ClinicalTrials.gov registry record · NA

Efficacy of RestoreX Penile Traction Therapy In Preserving Erectile Function Post-Prostatectomy

A NA study of Erectile Dysfunction Following Radical Prostatectomy, sponsored by Charitable Union for the Research and Education of Peyronie's Disease.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT05244486: Recruiting NA study of Erectile Dysfunction Following Radical Prostatectomy, sponsored by Charitable Union for the Research and Education of Peyronie's Disease.

NCT05244486 is a NA study of Erectile Dysfunction Following Radical Prostatectomy that is actively recruiting participants, run by Charitable Union for the Research and Education of Peyronie's Disease. The registered enrollment target is 200 participants, above the 166-participant average among 4 other Erectile Dysfunction Following Radical Prostatectomy trials with a reported enrollment target (20% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05244486, a NA study of Erectile Dysfunction Following Radical Prostatectomy, is actively recruiting participants, sponsored by Charitable Union for the Research and Education of Peyronie's Disease.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

Evaluate the efficacy of the RestoreX penile traction device in preserving erectile function in men undergoing robotic-assisted prostatectomy. This study will evaluate men undergoing prostatectomy with bilateral nerve preservation and preserved baseline erectile function (moderate ED or better). The primary outcome will be changes in the IIEF-EFD scores between groups at 6 months. Secondary outcomes include differences in questionnaire outcomes at 3, 6, and 9 months.

Primary Outcome

Compare erectile function between treatment and control cohorts, as assessed by the International Index of Erectile Function, Erectile Function Domain (IIEF-EFD) at 6-months post-prostatectomy. IIEF-EFD scores 1-30, with higher scores representing better function.

Interventions

  • DEVICE RestoreX 1-6 months (randomized phase)
  • DEVICE RestoreX 6-9 months (open label phase)

Study Locations (1)

Utah

  • The Male Fertility and Peyronie's Clinic - Orem

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2022-03-12
Est. Completion 2030-09-14
Phase NA

What NCT05244486 shows while recruiting

NCT05244486 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 166-participant average among 4 other Erectile Dysfunction Following Radical Prostatectomy trials with a reported enrollment target (20% higher).

The record links to 1 condition, with Erectile Dysfunction Following Radical Prostatectomy appearing as the primary indexed condition, and to 2 interventions - of which RestoreX 1-6 months (randomized phase) is the first listed.

NCT05244486 reports a single indexed study location in Utah.

Frequently Asked Questions

What is clinical trial NCT05244486 about?

NCT05244486 is a clinical study titled "Efficacy of RestoreX Penile Traction Therapy In Preserving Erectile Function Post-Prostatectomy". Evaluate the efficacy of the RestoreX penile traction device in preserving erectile function in men undergoing robotic-assisted prostatectomy. This study will evaluate men undergoing prostatectomy with bilateral nerve preservation and preserved baseline erectile function (moderate ED or better). The...

What is the current status of trial NCT05244486?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2022-03-12. Estimated completion is 2030-09-14.

What conditions does trial NCT05244486 study?

This clinical trial studies the following conditions: Erectile Dysfunction Following Radical Prostatectomy.

What interventions are being tested in trial NCT05244486?

The interventions under investigation include: RestoreX 1-6 months (randomized phase) (DEVICE), RestoreX 6-9 months (open label phase) (DEVICE).

Who is sponsoring clinical trial NCT05244486?

This trial is sponsored by Charitable Union for the Research and Education of Peyronie's Disease, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05244486 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Erectile Dysfunction Following Radical Prostatectomy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05244486, the US trial registry maintained by the National Library of Medicine. NCT05244486 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.